BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38072721)

  • 1. DLBCL arising from indolent lymphomas: How are they different?
    Parry EM; Roulland S; Okosun J
    Semin Hematol; 2023 Nov; 60(5):277-284. PubMed ID: 38072721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
    Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy.
    Sorigue M; Garcia O; Baptista MJ; Sancho JM; Tapia G; Mate JL; Feliu E; Navarro JT; Ribera JM
    Med Clin (Barc); 2017 Mar; 148(6):243-249. PubMed ID: 28038857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW.
    Adams CM; Mitra R; Gong JZ; Eischen CM
    Clin Cancer Res; 2017 Nov; 23(22):7119-7129. PubMed ID: 28855351
    [No Abstract]   [Full Text] [Related]  

  • 7. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.
    Pinyol M; Cobo F; Bea S; Jares P; Nayach I; Fernandez PL; Montserrat E; Cardesa A; Campo E
    Blood; 1998 Apr; 91(8):2977-84. PubMed ID: 9531609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to
    Witte H; Biersack H; Kopelke S; Rades D; Merz H; Bernard V; Lehnert H; Gebauer N
    Oncotarget; 2018 Apr; 9(28):19613-19622. PubMed ID: 29731969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
    Lawrie CH; Chi J; Taylor S; Tramonti D; Ballabio E; Palazzo S; Saunders NJ; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS
    J Cell Mol Med; 2009 Jul; 13(7):1248-60. PubMed ID: 19413891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene.
    Takimoto Y; Takafuta T; Imanaka F; Kuramoto A; Sasaki N; Nanba K
    Hiroshima J Med Sci; 1996 Jun; 45(2):69-73. PubMed ID: 8810134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.
    Lossos IS; Alizadeh AA; Diehn M; Warnke R; Thorstenson Y; Oefner PJ; Brown PO; Botstein D; Levy R
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8886-91. PubMed ID: 12077300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
    Yang X; Min X; He W
    Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma: the old and the new.
    Cabanillas F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: relationship to smoking.
    Nandi S; Yu J; Burger AM; Reinert LS; Gartenhaus RB
    Leuk Lymphoma; 2006 Sep; 47(9):1806-12. PubMed ID: 17064992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma classification update: B-cell non-Hodgkin lymphomas.
    Jiang M; Bennani NN; Feldman AL
    Expert Rev Hematol; 2017 May; 10(5):405-415. PubMed ID: 28395545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.
    Berglund M; Enblad G; Thunberg U; Amini RM; Sundström C; Roos G; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
    Mod Pathol; 2007 Jan; 20(1):63-75. PubMed ID: 17170743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.
    Hosry J; Miranda RN; Samaniego F; Economides MP; Torres HA
    Int J Cancer; 2018 Mar; 142(5):940-948. PubMed ID: 29047108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.